Literature DB >> 29910097

A novel compound heterozygous mutation in the POMK gene causing limb-girdle muscular dystrophy-dystroglycanopathy in a sib pair.

Sonja Strang-Karlsson1, Katherine Johnson2, Ana Töpf2, Liwen Xu3, Monkol Lek3, Daniel G MacArthur3, Olivera Casar-Borota4, Maria Williams5, Volker Straub2, Carina Wallgren-Pettersson6.   

Abstract

We describe two Finnish siblings in whom an incidentally detected elevated creatine kinase activity eventually led to a diagnosis of limb-girdle muscular dystrophy-dystroglycanopathy (Type C12; MDDGC12). When diagnosed at age 10 and 13 years, they were mildly affected with a slow or non-progressive disease course. The main symptoms comprised infrequent hip cramps triggered by flexion, neck cramps triggered by yawning, transient growing pains, calf hypertrophy and mild proximal muscle weakness. Their cognitive and motor developments were unremarkable and they were physically active. Whole-exome sequencing revealed compound heterozygous mutations, both of which were novel, in the protein O-mannosyl kinase (POMK) gene in both siblings; a missense mutation, p.Pro322Leu (c.965C > T), and a nonsense mutation, p.Arg46Ter (c.136C > T). The results were confirmed by Sanger sequencing, showing that the parents were heterozygous carriers of one mutation each. This report adds to the literature by providing phenotype and genotype data on this ultra-rare POMK-related dystroglycanopathy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dystroglycanopathy; LGMD12C; Limb-girdle muscular dystrophy-dystroglycanopathy type 12 C; MDDGC12; Muscular dystrophy; POMK; Protein-O-mannosyl kinase

Mesh:

Substances:

Year:  2018        PMID: 29910097      PMCID: PMC9429833          DOI: 10.1016/j.nmd.2018.04.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   3.538


  8 in total

1.  Isometric muscle torque in children 5 to 15 years of age: normative data.

Authors:  Meta Nyström Eek; Anna-Karin Kroksmark; Eva Beckung
Journal:  Arch Phys Med Rehabil       Date:  2006-08       Impact factor: 3.966

2.  POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations.

Authors:  Stefania Di Costanzo; Anuradha Balasubramanian; Heather L Pond; Anete Rozkalne; Chiara Pantaleoni; Simona Saredi; Vandana A Gupta; Christine M Sunu; Timothy W Yu; Peter B Kang; Mustafa A Salih; Marina Mora; Emanuela Gussoni; Christopher A Walsh; M Chiara Manzini
Journal:  Hum Mol Genet       Date:  2014-06-11       Impact factor: 6.150

3.  Congenital mirror movements in a patient with alpha-dystroglycanopathy due to a novel POMK mutation.

Authors:  Didem Ardicli; Rahsan Gocmen; Beril Talim; Rosanne Sprute; Goknur Haliloglu; Sebahattin Cirak; Haluk Topaloglu
Journal:  Neuromuscul Disord       Date:  2016-12-23       Impact factor: 4.296

4.  A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population.

Authors:  Stojan Perić; Jelena Nikodinović Glumac; Ana Töpf; Dušanka Savić-Pavićević; Lauren Phillips; Katherine Johnson; Marcus Cassop-Thompson; Liwen Xu; Marta Bertoli; Monkol Lek; Daniel MacArthur; Miloš Brkušanin; Sanja Milenković; Vedrana Milić Rašić; Bojan Banko; Ružica Maksimović; Hanns Lochmüller; Vidosava Rakočević Stojanović; Volker Straub
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

5.  POMK mutation in a family with congenital muscular dystrophy with merosin deficiency, hypomyelination, mild hearing deficit and intellectual disability.

Authors:  Anja von Renesse; Mina V Petkova; Susanne Lützkendorf; Jan Heinemeyer; Esther Gill; Christoph Hübner; Arpad von Moers; Werner Stenzel; Markus Schuelke
Journal:  J Med Genet       Date:  2014-02-20       Impact factor: 6.318

6.  Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry.

Authors:  Lucas T Jae; Matthijs Raaben; Moniek Riemersma; Ellen van Beusekom; Vincent A Blomen; Arno Velds; Ron M Kerkhoven; Jan E Carette; Haluk Topaloglu; Peter Meinecke; Marja W Wessels; Dirk J Lefeber; Sean P Whelan; Hans van Bokhoven; Thijn R Brummelkamp
Journal:  Science       Date:  2013-03-21       Impact factor: 47.728

7.  A general framework for estimating the relative pathogenicity of human genetic variants.

Authors:  Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

8.  Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness.

Authors:  Katherine Johnson; Ana Töpf; Marta Bertoli; Lauren Phillips; Kristl G Claeys; Vidosava Rakocevic Stojanovic; Stojan Perić; Andreas Hahn; Paul Maddison; Ela Akay; Alexandra E Bastian; Anna Łusakowska; Anna Kostera-Pruszczyk; Monkol Lek; Liwen Xu; Daniel G MacArthur; Volker Straub
Journal:  Orphanet J Rare Dis       Date:  2017-11-17       Impact factor: 4.123

  8 in total
  3 in total

1.  Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness.

Authors:  Katherine Johnson; Marta Bertoli; Lauren Phillips; Ana Töpf; Peter Van den Bergh; John Vissing; Nanna Witting; Shahriar Nafissi; Shirin Jamal-Omidi; Anna Łusakowska; Anna Kostera-Pruszczyk; Anna Potulska-Chromik; Nicolas Deconinck; Carina Wallgren-Pettersson; Sonja Strang-Karlsson; Jaume Colomer; Kristl G Claeys; Willem De Ridder; Jonathan Baets; Maja von der Hagen; Roberto Fernández-Torrón; Miren Zulaica Ijurco; Juan Bautista Espinal Valencia; Andreas Hahn; Hacer Durmus; Tracey Willis; Liwen Xu; Elise Valkanas; Thomas E Mullen; Monkol Lek; Daniel G MacArthur; Volker Straub
Journal:  Skelet Muscle       Date:  2018-07-30       Impact factor: 4.912

2.  N-glycosylated SGK196 suppresses the metastasis of basal-like breast cancer cells.

Authors:  Ci Xu; Meichao Zhang; Lei Bian; Yanyan Li; Yuan Yao; Dong Li
Journal:  Oncogenesis       Date:  2020-01-08       Impact factor: 7.485

3.  Further evidence for POMK as candidate gene for WWS with meningoencephalocele.

Authors:  Luisa Paul; Katrin Rupprich; Adela Della Marina; Anja Stein; Magdeldin Elgizouli; Frank J Kaiser; Bernd Schweiger; Angela Köninger; Antonella Iannaccone; Ute Hehr; Heike Kölbel; Andreas Roos; Ulrike Schara-Schmidt; Alma Kuechler
Journal:  Orphanet J Rare Dis       Date:  2020-09-09       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.